259 related articles for article (PubMed ID: 32213163)
41. Impact of reversal strategies on the incidence of postoperative residual paralysis after rocuronium relaxation without neuromuscular monitoring: A partially randomised placebo controlled trial.
Nemes R; Fülesdi B; Pongrácz A; Asztalos L; Szabó-Maák Z; Lengyel S; Tassonyi E
Eur J Anaesthesiol; 2017 Sep; 34(9):609-616. PubMed ID: 28030444
[TBL] [Abstract][Full Text] [Related]
42. Sugammadex for the reversal of muscle relaxation in general anaesthesia: a systematic review and economic assessment.
Chambers D; Paulden M; Paton F; Heirs M; Duffy S; Craig D; Hunter J; Wilson J; Sculpher M; Woolacott N
Health Technol Assess; 2010 Jul; 14(39):1-211. PubMed ID: 20688009
[TBL] [Abstract][Full Text] [Related]
43. Sugammadex compared with neostigmine/glycopyrrolate for routine reversal of neuromuscular block: a systematic review and economic evaluation.
Paton F; Paulden M; Chambers D; Heirs M; Duffy S; Hunter JM; Sculpher M; Woolacott N
Br J Anaesth; 2010 Nov; 105(5):558-67. PubMed ID: 20935005
[TBL] [Abstract][Full Text] [Related]
44. [Efficacy of sugammadex in the reversal of neuromuscular blockade induced by rocuronium in long-duration surgery: under inhaled vs. intravenous anesthesia].
Veiga-Ruiz G; Domínguez N; Orozco J; Janda M; Hofmockel R; Alvarez-Gómez JA
Rev Esp Anestesiol Reanim; 2009; 56(6):349-54. PubMed ID: 19725342
[TBL] [Abstract][Full Text] [Related]
45. Sugammadex for reversal of neuromuscular blockade in pediatric patients: Results from a phase IV randomized study.
Voss T; Wang A; DeAngelis M; Speek M; Saldien V; Hammer GB; Wrishko R; Herring WJ
Paediatr Anaesth; 2022 Mar; 32(3):436-445. PubMed ID: 34878707
[TBL] [Abstract][Full Text] [Related]
46. Sugammadex Versus Neostigmine for Neuromuscular Block Reversal and Postoperative Pulmonary Complications in Patients Undergoing Resection of Lung Cancer.
Yu Y; Wang H; Bao Q; Zhang T; Chen B; Ding J
J Cardiothorac Vasc Anesth; 2022 Sep; 36(9):3626-3633. PubMed ID: 35662514
[TBL] [Abstract][Full Text] [Related]
47. Efficacy of sugammadex for the reversal of moderate and deep rocuronium-induced neuromuscular block in patients pretreated with intravenous magnesium: a randomized controlled trial.
Czarnetzki C; Tassonyi E; Lysakowski C; Elia N; Tramèr MR
Anesthesiology; 2014 Jul; 121(1):59-67. PubMed ID: 24608361
[TBL] [Abstract][Full Text] [Related]
48. A randomized trial evaluating the safety profile of sugammadex in high surgical risk ASA physical class 3 or 4 participants.
Herring WJ; Mukai Y; Wang A; Lutkiewicz J; Lombard JF; Lin L; Watkins M; Broussard DM; Blobner M
BMC Anesthesiol; 2021 Oct; 21(1):259. PubMed ID: 34711192
[TBL] [Abstract][Full Text] [Related]
49. Low-Dose or High-Dose Rocuronium Reversed with Neostigmine or Sugammadex for Cesarean Delivery Anesthesia: A Randomized Controlled Noninferiority Trial of Time to Tracheal Intubation and Extubation.
Stourac P; Adamus M; Seidlova D; Pavlik T; Janku P; Krikava I; Mrozek Z; Prochazka M; Klucka J; Stoudek R; Bartikova I; Kosinova M; Harazim H; Robotkova H; Hejduk K; Hodicka Z; Kirchnerova M; Francakova J; Obare Pyszkova L; Hlozkova J; Sevcik P
Anesth Analg; 2016 May; 122(5):1536-45. PubMed ID: 26974018
[TBL] [Abstract][Full Text] [Related]
50. [Analysis of sugammadex for antagonistic neuromuscular block in patients with radical resection of lung cancer under thoracoscope].
Ba YF; Liu YN; He SH; Li HM; Wang HR; Zhu JP; Xing WQ; Li CS
Zhonghua Yi Xue Za Zhi; 2020 Jan; 100(3):213-219. PubMed ID: 32008289
[No Abstract] [Full Text] [Related]
51. Association between reversal agents (sugammadex vs. neostigmine) for neuromuscular block and postoperative pulmonary complications: A retrospective analysis.
Ren A; Fan M; Gu Z; Liang X; Xu L; Liu C; Wang D; Chang H; Zhu M
Br J Clin Pharmacol; 2024 Jul; 90(7):1667-1676. PubMed ID: 38583490
[TBL] [Abstract][Full Text] [Related]
52. Sugammadex versus neostigmine reversal of moderate rocuronium-induced neuromuscular blockade in Korean patients.
Woo T; Kim KS; Shim YH; Kim MK; Yoon SM; Lim YJ; Yang HS; Phiri P; Chon JY
Korean J Anesthesiol; 2013 Dec; 65(6):501-7. PubMed ID: 24427455
[TBL] [Abstract][Full Text] [Related]
53. Electromyographic activity of the diaphragm during neostigmine or sugammadex-enhanced recovery after neuromuscular blockade with rocuronium: a randomised controlled study in healthy volunteers.
Schepens T; Cammu G; Saldien V; De Neve N; Jorens PG; Foubert L; Vercauteren M
Eur J Anaesthesiol; 2015 Jan; 32(1):49-57. PubMed ID: 25111539
[TBL] [Abstract][Full Text] [Related]
54. Effect of reversal of deep neuromuscular block with sugammadex or moderate block by neostigmine on shoulder pain in elderly patients undergoing robotic prostatectomy.
Williams WH; Cata JP; Lasala JD; Navai N; Feng L; Gottumukkala V
Br J Anaesth; 2020 Feb; 124(2):164-172. PubMed ID: 31780139
[TBL] [Abstract][Full Text] [Related]
55. Neuromuscular Blockade and Reversal Agent Practice Variability in the US Inpatient Surgical Settings.
Bash LD; Turzhitsky V; Black W; Urman RD
Adv Ther; 2021 Sep; 38(9):4736-4755. PubMed ID: 34319550
[TBL] [Abstract][Full Text] [Related]
56. Efficacy and safety of sugammadex in the reversal of deep neuromuscular blockade induced by rocuronium in patients with end-stage renal disease: A comparative prospective clinical trial.
de Souza CM; Tardelli MA; Tedesco H; Garcia NN; Caparros MP; Alvarez-Gomez JA; de Oliveira Junior IS
Eur J Anaesthesiol; 2015 Oct; 32(10):681-6. PubMed ID: 26225497
[TBL] [Abstract][Full Text] [Related]
57. Relationship between first-twitch depression and train-of-four ratio during sugammadex reversal of rocuronium-induced neuromuscular blockade.
Kim KS; Oh YN; Kim TY; Oh SY; Sin YH
Korean J Anesthesiol; 2016 Jun; 69(3):239-43. PubMed ID: 27274368
[TBL] [Abstract][Full Text] [Related]
58. Administration of rocuronium (Org 9426) by continuous infusion and its reversibility with anticholinesterases.
McCoy EP; Mirakhur RK; Maddineni VR; Loan PB; Connolly F
Anaesthesia; 1994 Nov; 49(11):940-5. PubMed ID: 7802236
[TBL] [Abstract][Full Text] [Related]
59. Is lower-dose sugammadex a cost-saving strategy for reversal of deep neuromuscular block? Facts and fiction.
de Boer HD; Carlos RV; Brull SJ
BMC Anesthesiol; 2018 Nov; 18(1):159. PubMed ID: 30400850
[TBL] [Abstract][Full Text] [Related]
60. Reversibility of Rocuronium-Induced Deep Neuromuscular Block with Sugammadex in Infants and Children-A Randomized Study.
Matsui M; Konishi J; Suzuki T; Sekijima C; Miyazawa N; Yamamoto S
Biol Pharm Bull; 2019 Oct; 42(10):1637-1640. PubMed ID: 31406051
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
